Latest Views & News

Advanced Oncotherapy – more spoofery as NED buys yet more shares

By Nigel Somerville, the Deputy Sheriff of AIM | Tuesday 25 April 2017


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


AIM-listed Advanced Oncotherapy (AVO) – teetering on the brink of having to call an EGM to reduce its nominal share capital under the terms of its death-spiral funding package with Bracknor – has announced yet another director share purchase, the fourth just this month (if we ignore the botched 7am RNS of 4 April). As ever, this is just a spoof in order to encourage more buying in the market so as to allow Bracknor to offload more of its death-spiral conversion shares as Advanced hopes and prays for the next £1.235 million tranche of funding before the coffers run dry.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

SAGA

The ongoing saga of woe at Saga

 

Quiz

The ShareProphets Sunday Pub Quiz #160

 

VCP

Gyrations at Victoria Carpets

 

MADE

GOTCHA: Made.com admits it is fucked

 

Bull

Stuff happens but we are not stuffed

 

Quiz

The ShareProphets Sunday Pub Quiz #159

 

OCDO

Challenges continue at Ocado

 

ICON

Iconic Labs – back from the dead?

 

PUR

Pure Gold – Pure Ramping!

Sunday »

Quiz

The ShareProphets Sunday Pub Quiz #158

 

ORCA

Buy Orcadian Energy